The adjusted risk for myocardial infarction was significantly higher in diabetic patients on insulin therapy than diabetic patients on oral antidiabetic drugs (adjusted HR = 3.03 [1.09–8.43], p = 0.034). The gene discussed is INS; the disease is myocardial infarction.